Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duogestan in early postmenopausal women for quality of life
NL-OMON34007Phase 4Withdrawn
- Sponsor
- Maastricht University Medical Center+
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of estradiol + progesterone in menopause, sponsored by Maastricht University Medical Center+. Primary endpoint: Health-related quality of life. Planned start Aug 2009; status: withdrawn.
02
Drugs
estradiol + progesterone
03
Conditions
menopause
Beyond the preview
Go deeper on NL-OMON34007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34007.